Please assess the completion status of the following clinical trial:

Trial Title: Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients of age 18 years or above~* Patients diagnosed with stage 1 or stage 2 essential hypertension~* Normal physical examination findings, electrocardiogram (ECG) results and chest x-ray; or abnormal findings judged by the Investigator to be not clinically significant~Exclusion Criteria:~* Secondary hypertension or severe hypertension~* Clinically significant cardiovascular disease or heart failure~* A medical contraindication to discontinuing a current antihypertensive therapy~* History of Type 1 diabetes mellitus

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): Nebivolol and Valsartan free tablet combination

Based on this trial design, predict the completion outcome and termination type (if applicable).